GENOSAFE SAS - France 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:500-600
Total Number of Projects:68
Total Project Funding:600-700
Networking Rank (Reputation):800-900
Networking Rank (Reputation):800-900
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2007
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 11.773.000 299.658 1
2018 0 12.247.620 734.970 2
2012 0 17.970.946 1.693.219 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
GENETHON4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
FONDAZIONE TELETHON2
MEDIZINISCHE HOCHSCHULE HANNOVER2
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA2
UNIVERSITY COLLEGE LONDON2
3P BIOPHARMACEUTICALS SL1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
AMSTERDAM BIOTHERAPEUTICS UNIT1
ASPHALION SL1
ASSOCIATION FRANCAISE DE CRIGLER NAJJAR1
ASTELLAS PHARMA EUROPE BV1
AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII1
BAYER1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EUROPAEISCHES INSTITUT FUER FORSCHUNG UND ENTWICKLUNG VON TRANSPLANTATIONSSTRATEGIEN1
FINOVATIS1
GATC BIOTECH1
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT1
HACETTEPE UNIVERSITESI1
HET ROTTERDAMS OOGHEELKUNDIG INSTITUUT BV1
HOTSWAP STOCKHOLM AB1
IGEA1
INFORMA1
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA1
INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ1
JANSSEN PHARMACEUTICA NV1
KLINIKUM DER JOHANN WOLFGANG GOETHE UNIVERSITAET1
LONZA1
LUND UNIVERSITY1
LYSOGENE1
MAGISTRAT DER STADT WIEN1
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN1
MC TOXICOLOGY CONSULTING1
MIMETAS BV1
NOVARTIS PHARMA1
NOVARTIS PHARMA1
NOVO NORDISK1
PAUL EHRLICH INSTITUT1
PFIZER LIMITED1
PHARMACOIDEA FEJLESZTO ES SZOLGALTATO KFT1
REGENX BIOSCIENCES LLC1
REITHERA1
RHEINISCH WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN1
SANOFIAVENTIS1
SPARK THERAPEUTICS INC1
STICHTING OOGZIEKENHUIS ROTTERDAM1
SYNVACCINE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TAKIS1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE ROSALIND FRANKLIN INSTITUTE1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF SHEFFIELD1
UD GENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATAS FEJLESZTESI ES SZOLGALTATO KFT1
UNIVERSIDAD DE NAVARRA1
UNIVERSITA DEGLI STUDI DELLA CAMPANIA LUIGI VANVITELLI1
UNIVERSITa DEGLI STUDI DI NAPOLI 'FEDERICO II'1
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II1
UNIVERSITAET ZUERICH1
UNIVERSITAETSKLINIKUM AACHEN1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITE DE GENEVE1
UNIVERSITY OF CAMBRIDGE1
UNIVERSITY OF EASTERN FINLAND1
UNIVERSITY OF LEICESTER1
VISCOFAN1

Constancy:

Total number of partners: 82
Partner loyalty:
Frequent Partner: (> 2 projects): 4
Rare Partner: 78
Frequent / Rare Partner Ratio: 0.05

Project overview:

Start dateProjectacronymrolefundingpartners
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2018-01-01Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB UshTherparticipant5.998.5169
2018-01-01Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome CureCNparticipant6.249.10411
2012-12-01Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) NET4CGDparticipant5.999.60711
2012-12-01Clinical trial of gene therapy for MPS VI - a severe lysosomal storage disorder MEUSIXparticipant5.995.0418
2012-11-01"Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)" TARGETAMDparticipant5.976.29815

Alias institution names:

  • GENOSAFE SAS